Understanding the Risks of Investing in NOV Inc (NOV)

Anna Perez

In a filing, NOV Inc revealed its Director Kendall Christian S acquired Company’s shares for reported $1.01 million on Nov 21 ’25. In the deal valued at $14.46 per share,70,000 shares were bought. As a result of this transaction, Kendall Christian S now holds 85,949 shares worth roughly $1.51 million.

Then, CHRISTY NOVAK bought 21,435 shares, generating $316,078 in total proceeds.

Before that, CHRISTY NOVAK bought 450 shares. NOV Inc shares valued at $6,766 were divested by the Officer at a price of $15.04 per share.

JP Morgan downgraded its NOV Inc [NOV] rating to a Neutral from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in late March from “a Sector perform” to “an Outperform”. Evercore ISI also remained covering NOV and has decreased its forecast on January 15, 2025 with a “an In-line” recommendation from previously “an Outperform” rating. Seaport Research Partners revised its rating on January 06, 2025. It rated NOV as “a Neutral” which previously was an “a Buy”.

Price Performance Review of NOV

On Monday, NOV Inc [NYSE:NOV] saw its stock fall -0.17% to $17.53. Over the last five days, the stock has gained 6.83%. NOV Inc shares have risen nearly 19.83% since the year began. Nevertheless, the stocks have risen 12.16% over the past one year.

How much short interest is there in NOV Inc?

A steep rise in short interest was recorded in NOV Inc stocks on 2025-12-15, dropping by -2.1 million shares to a total of 21.95 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 24.06 million shares. There was a decline of -9.59%, which implies that there is a negative sentiment for the stock.

The most recent change occurred on December 19, 2024 when Piper Sandler began covering the stock and recommended ‘”a Neutral”‘ rating along with a $17 price target.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.